Chemoresection by mitomycin C compared to transurethral resection of bladder tumor in patients with recurrent nonmuscle-invasive bladder cancer: A systematic review and meta-analysis

Risk Stratification of Nonmuscle Invasive Bladder Cancer and Innovative Approaches to Management of Ta Low-Grade Tumors

“…These are innovative and evolving strategies designed as an alternative to the endoscopic invasive TURBT under general anesthesia. 14 These grew out in part from the marker lesion trial design where a small (usually 5-10 mm) TaLG tumor was left in place to determine the activity of an intravesical or oral treatment. Office cystoscopic biopsy and urine cytology can be used to assess the likelihood that the target tumor is low or high grade.…”